47.39
Precedente Chiudi:
$47.03
Aprire:
$44.59
Volume 24 ore:
3.82M
Relative Volume:
0.72
Capitalizzazione di mercato:
$8.47B
Reddito:
$1.27B
Utile/perdita netta:
$-245.03M
Rapporto P/E:
-33.68
EPS:
-1.4071
Flusso di cassa netto:
$-245.36M
1 W Prestazione:
+4.09%
1M Prestazione:
-11.10%
6M Prestazione:
-46.93%
1 anno Prestazione:
-5.01%
Tempus Ai Inc Stock (TEM) Company Profile
Nome
Tempus Ai Inc
Settore
Industria
Telefono
800-976-5448
Indirizzo
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, HQY, WAY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
TEM
Tempus Ai Inc
|
47.39 | 8.47B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
VEEV
Veeva Systems Inc
|
173.98 | 28.42B | 3.20B | 908.91M | 1.39B | 5.4168 |
|
BTSG
Brightspring Health Services Inc
|
43.10 | 8.28B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
HQY
Healthequity Inc
|
84.67 | 7.15B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
WAY
Waystar Holding Corp
|
23.74 | 4.55B | 1.10B | 112.09M | 283.19M | 0.6096 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-19 | Iniziato | Mizuho | Outperform |
| 2026-02-17 | Iniziato | Robert W. Baird | Outperform |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-10-21 | Downgrade | TD Cowen | Buy → Hold |
| 2025-10-20 | Iniziato | Canaccord Genuity | Buy |
| 2025-09-02 | Iniziato | H.C. Wainwright | Buy |
| 2025-04-21 | Iniziato | BTIG Research | Buy |
| 2025-02-25 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-02-12 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | Ripresa | TD Cowen | Buy |
| 2024-12-13 | Iniziato | Wolfe Research | Outperform |
| 2024-12-09 | Iniziato | Guggenheim | Buy |
| 2024-11-11 | Downgrade | Stifel | Buy → Hold |
| 2024-10-02 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-08-12 | Iniziato | Piper Sandler | Neutral |
| 2024-07-09 | Iniziato | BofA Securities | Buy |
| 2024-07-09 | Iniziato | JP Morgan | Overweight |
| 2024-07-09 | Iniziato | Longbow | Buy |
| 2024-07-09 | Iniziato | Loop Capital | Buy |
| 2024-07-09 | Iniziato | Morgan Stanley | Overweight |
| 2024-07-09 | Iniziato | Needham | Buy |
| 2024-07-09 | Iniziato | Stifel | Buy |
| 2024-07-09 | Iniziato | TD Cowen | Buy |
| 2024-07-09 | Iniziato | William Blair | Outperform |
Mostra tutto
Tempus Ai Inc Borsa (TEM) Ultime notizie
Top Artificial Intelligence Stocks To Watch NowApril 5th - MarketBeat
Tempus AI: A Stock Caught Between Institutional Backing and Market Skepticism - AD HOC NEWS
Best Artificial Intelligence Stocks To Add to Your WatchlistApril 4th - marketbeat.com
Tempus AI, Inc. (TEM) stock price, news, quote and history - Yahoo Finance UK
Best Artificial Intelligence Stocks To Keep An Eye OnApril 3rd - MarketBeat
Tempus AI: A Dual-Engine AI Model - Seeking Alpha
Tempus, Medtronic find AI alert tool can improve cardiac valve care - Crain's Chicago Business
Tempus AI, Inc. (TEM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Tempus AI Stock Gains Following the ALERT Trial Result Announcement - TradingView
Suits Against Tempus AI Test Legal Lines for Mining Genetic Data - Law.com
Assessing Tempus AI (TEM) Valuation After ALERT Cardiology Trial Results And Expanded Merck Collaboration - Yahoo Finance
Tempus AI: 450-Petabyte Moat, High-Growth Upside At A Discount (NASDAQ:TEM) - Seeking Alpha
Can Tempus AI’s (TEM) ALERT Trial Quietly Redefine Its Real-World Data Advantage in Cardiology? - Yahoo Finance
Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease - 01net
What's Fueling TEM Diagnostics Segment's Strong 2026 Outlook? - Yahoo Finance Singapore
Tempus AI Stock Jumps, ALERT Trial Results Boost EHR Automation BuzzTempus AI (NASDAQ:TEM) - Benzinga
Tempus AI, Inc. Announces Results from ALERT Trial - marketscreener.com
Tempus AI, Medtronic Report Positive Clinical Trial Results for Medical Alert System - MarketScreener
Tempus and Medtronic announce alert trial results showing AI-driven EHR notifications improve treatment for significant valvular heart disease - marketscreener.com
Tempus And Medtronic Announce Alert Trial Results Showing Ai-Driven Ehr Notifications Improve Treatment For Significant Valvular Heart Disease - TradingView
Tempus AI trial shows automated alerts improve heart valve care By Investing.com - Investing.com India
Tempus AI trial shows automated alerts improve heart valve care - Investing.com
TEM vs. DOCS: Which Medical Info Systems Stock Is the Better Pick Now? - The Globe and Mail
Jim Cramer on Tempus AI: “It’s a Decent Spec, I Would Hold on to Some, But Not All” - Insider Monkey
Hims & Hers Expands Personalized Digital Healthcare Platform - TradingView
2 AI Healthcare Stocks to Buy Right Now - The Globe and Mail
Tempus AI, Inc.Class A Common Stock (NQ: TEM - FinancialContent
Tempus AI: An Attractive Entry Point At Current Prices (NASDAQ:TEM) - Seeking Alpha
Tempus AI (TEM) Analyst Rating Update: Guggenheim Lowers Price T - GuruFocus
Buy, sell, or hold? Jim Cramer’s take on 18 callers’ stocks as crude oil prices climb - MSN
Guggenheim Has Lowered Expectations for Tempus AI (NASDAQ:TEM) Stock Price - MarketBeat
Guggenheim Maintains Tempus AI(TEM.US) With Buy Rating, Cuts Target Price to $60 - Moomoo
Tempus AI Insider Sold Shares Worth $7,711,150, According to a Recent SEC Filing - MarketScreener
Top Artificial Intelligence Stocks To Follow TodayMarch 29th - marketbeat.com
TEM Stock Quote Price and Forecast - CNN
Artificial Intelligence Stocks To Keep An Eye OnMarch 28th - marketbeat.com
Is Tempus AI’s (TEM) Oncology Data Push Quietly Redefining Its Long-Term Moat? - simplywall.st
Eric Lefkofsky Sells 166,250 Shares of Tempus AI (NASDAQ:TEM) Stock - MarketBeat
Lightning round: Tempus AI is a 'decent spec', says Jim Cramer - MSN
Cathie Wood Chooses Medical AI Over Mark Zuckerberg: Ark Loads Up On TEM Stock, Dumps Meta Shares - AOL.com
# Lefkofsky Eric P, CEO of Tempus AI, sells $7.7 million in stock - Investing.com India
Tempus AI (TEM) CEO-linked entities sell 166K shares under 10b5-1 plan - Stock Titan
Tempus AI Inc. (TEM) touted as a buy amid focus on healthcare opportunities - MSN
Tempus AI, Daiichi Sankyo team up to boost cancer drug trials with AI - Mugglehead Magazine
Artificial Intelligence Stocks To ConsiderMarch 27th - MarketBeat
Vanguard disaggregates holdings; reports 0 shares of Tempus AI (TEM) - stocktitan.net
Why Tempus AI Shares Are Sliding Yet Again - TipRanks
Tempus AI stock near 1-year low: Cathie Wood’s ARK buys more while offloading Nvidia, Meta, other tech plays - MSN
Tempus AI, Inc. $TEM Shares Bought by SG Americas Securities LLC - MarketBeat
Cathie Wood’s ARK sells Meta and Nvidia stocks, buys Tempus AI - Investing.com
Tempus AI Stock Near 1-Year Low: Cathie Wood’s ARK Buys More While Offloading Nvidia, Meta, Other Tech Plays - Stocktwits
Tempus Ai Inc Azioni (TEM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):